Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Alexion Pharmaceuticals (United States)
InstitutionResearch output, impact & collaborations
Alexion Pharmaceuticals (United States) is a research organisation in Boston, US. OpenAlex records 1,356 works and 169,643 citations for it. 466 researchers list it as their most recent affiliation.
1,356
Works
169,643
Citations
466
Researchers
33.7
Avg h-index
How has Alexion Pharmaceuticals (United States)'s publication output changed over time?
ScholarIQpublication output · 2014–2019
Output grew200% over the shown period — from 1 works in 2014 to 3 in 2019.
1
1
2
2
3
3
201420152016201720182019
Who are the most-cited researchers behind Alexion Pharmaceuticals (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on Alexion Pharmaceuticals (United States)?
ScholarIQmost cited works
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Eric L. Simpson, Thomas Bieber, Emma Guttman‐Yassky, Lisa A. Beck, Andrew Blauvelt, Michael J. Cork, Jonathan I. Silverberg, Mette Deleuran, Yoko Kataoka, J.‐P. Lacour, Külli Kingo, Margitta Worm, Yves Poulin, Andreas Wollenberg, Yuhwen Soo, Neil M.H. Graham, Gianluca Pirozzi, Bolanle Akinlade, Heribert Staudinger, Vera Mastey, Laurent Eckert, Abhijit Gadkari, Neil Stahl, George D. Yancopoulos, Marius Ardeleanu
New England Journal of Medicine. 20162,067 CitationsOPEN ACCESS
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Mario Castro, Jonathan Corren, Ian Pavord, Jorge Máspero, Sally E. Wenzel, Klaus F. Rabe, William W. Busse, Linda Ford, Lawrence Sher, J. Mark FitzGerald, Constance H. Katelaris, Yuji Tohda, Bingzhi Zhang, Heribert Staudinger, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Asif Khan, Jingdong Chao, Renata Martincova, Neil M.H. Graham, Jennifer D. Hamilton, Brian N. Swanson, Neil Stahl, George D. Yancopoulos, Ariel Teper
New England Journal of Medicine. 20181,961 CitationsOPEN ACCESS
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
Lisa A. Beck, Diamant Thaçi, Jennifer D. Hamilton, Neil M.H. Graham, Thomas Bieber, Ross E. Rocklin, Jeffrey E. Ming, Haobo Ren, Richard Kao, Eric L. Simpson, Marius Ardeleanu, Steven P. Weinstein, Gianluca Pirozzi, Emma Guttman‐Yassky, Mayte Suárez‐Fariñas, Melissa Hager, Neil Stahl, George D. Yancopoulos, Allen Radin
New England Journal of Medicine. 20141,414 Citations
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham, Jennifer Clay Cather, Jamie Weisman, David M. Pariser, Eric L. Simpson, Kim Papp, Hyuck-Ki Hong, Diana Rubel, Peter Foley, Errol P. Prens, C.E.M. Griffiths, Takafumi Etoh, Pedro Herranz, Ramón M. Pujol, Jacek C. Szepietowski, Karel Ettler, Lajos Kemény, Xiaoping Zhu, Bolanle Akinlade, Thomas Hultsch, Vera Mastey, Abhijit Gadkari, Laurent Eckert, Nikhil Amin, Neil M.H. Graham, Gianluca Pirozzi, Neil Stahl, George D. Yancopoulos, Brad Shumel
The Lancet. 20171,258 CitationsOPEN ACCESS
Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Klaus F. Rabe, Parameswaran Nair, Guy Brusselle, Jorge Máspero, Mario Castro, Lawrence Sher, Hongjie Zhu, Jennifer D. Hamilton, Brian N. Swanson, Asif Khan, Jingdong Chao, Heribert Staudinger, Gianluca Pirozzi, Christian Antoni, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Neil M.H. Graham, Neil Stahl, George D. Yancopoulos, Ariel Teper
New England Journal of Medicine. 20181,176 CitationsOPEN ACCESS
How much of the research on Alexion Pharmaceuticals (United States) is open access?
ScholarIQopen access share
75%OPEN ACCESS
Gold
0%
Green
8%
Hybrid
42%
Bronze
25%
Closed
25%